Vice President Clinical Development
Servier Pharmaceuticals
Vice President Clinical Development, Head of Cancer Metabolism Global Development at Servier Pharmaceuticals. Dr. Pandya has over a decade of drug development experience. Oversees the clinical development of the IDH inhibitors and asparaginase products through early and late stage clinical studies. Dr. Pandya earned her Doctor of Medicine from Tufts University School of Medicine and completed her residency in internal medicine and fellowship in Hematology/Oncology at the Beth Israel Deaconess Medical Center (BIDMC), a Harvard University teaching hospital. She continued her career as a board certified Hematologist/Oncologist practicing at BIDMC with a focus on early phase clinical development as the Associate Director of the Phase 1 experimental therapeutics program, while maintaining a clinical practice in GI and Breast Oncology.
